MB ChB, PhD, FRCP Edin, FRCOG
Personal Chair (Clinical)
- About
-
- Email Address
- zosia@abdn.ac.uk
- Telephone Number
- +44 (0)1224 552120
- Telephone Number
- +44 (0)1224 437931
- Office Address
- School/Department
- School of Medicine, Medical Sciences and Nutrition
Personal Assistant- Personal Assistant
- Miss Debbie Coutts
- Personal Assistant Email Address
- debbie.coutts@abdn.ac.uk
- Personal Assistant Telephone Number
- +44 (0)1224 437300
Biography
Zosia Miedzybrodzka studied medicine and trained as a clinical researcher and specialist genetics doctor at University of Aberdeen and with the NHS Grampian in the North of Scotland.
She uses the roles of service clinical director of NHS laboratory and clinical genetics in the north of Scotland, and honorary consultant clinical geneticist to deliver high quality impactful research in gene discovery, characterisation, clinical epidemiology and rigorous technology assessment. Her work is highly collaborative both locally, nationally and internationally and she has particular interests in evaluation of genomics, Huntington’s disease (HD) and prevention in hereditary cancer.
As chair of the Scottish genetics laboratories’ consortium she led NHS Scotland from testing for small panels of genes to exomes, with widespread cancer testing and beginnings of pharmacogenomics in everyday clinical practice and she led the NHS Scotland in 100,000 genomes project.
Recently her work on a breast and ovarian cancer gene, BRCA1, in Orkney came to public attention, leading to Woman and Home Magazine celebrating her as “Britain’s most amazing woman- Science Pioneer” for 2023.
Qualifications
- PhD Clinical Medicine1995 - University of Aberdeen
- MB ChB Medicine and Surgery1988 - University of Aberdeen
- FRCP Edin Fellowship of Royal College of Physicians of Edinburgh2008 - Royal College of Physicians of Edinburgh
- FRCOG Obstetrics and Gynaecology2010 - Royal of Obstetricians and Gynaecologists
Memberships and Affiliations
- Internal Memberships
-
Centre for Genome-enabled Biology and Medicine
Institute of Medical Sciences
- External Memberships
-
Service Clinical Director- Genetics & Honorary Consultant Clinical Geneticist NHS Grampian
Member: Scotland's rare disease strategy implementation board, RCP / RCPath Joint Committee for Genomics medicine, Association of Medical Royal Colleges Genomics professional partnerships board, Steering group Scottish Strategic Network for Genomic Medicine.
Prizes and Awards
Woman and Home Magazine “Britain’s most amazing women awards- Science Pioneer” 2023.
- Research
-
Research Overview
Professor of Medical Genetics, University of Aberdeen
Honorary Consultant Clinical Geneticist, NHS Grampian
Service Clinical Director- Genetics, NHS Grampian
(NHS Grampian Genomics & Molecular Pathology Laboratory & North of Scotland Clinical Genetics Service)
Woman & Home Magazine “Britain’s Most Amazing Women Awards” – Science Pioneer 2023
Zosia Miedzybrodzka studied medicine at University of Aberdeen, graduating with commendation as best female student in 1988. Following basic medical training, she was awarded the prestigious Scottish Hospitals Endowments Research Trust Cruden research scholarship for 1990, then a three-year Wellcome grant during which she completed her University of Aberdeen PhD bringing genetics laboratory science, health services research and health economics to a randomised trial of approaches to population-based antenatal carrier screening for cystic fibrosis (CF). The programme not only established PCR based multiplex direct mutation testing in the Aberdeen NHS genetics laboratory, documented mutation frequencies in CF in northern Scotland, but also was also one of the first exemplars of the use of willingness to pay as a quantitative value-based measure of healthcare intervention which is now widespread in health technology assessment.
Zosia gained entry to higher specialist training in clinical genetics through MRCOG and was appointed clinical lecturer at University of Aberdeen in 1998. Appointed senior lecturer and honorary consultant clinical geneticist through promotion she developed her research interests leading clinical epidemiology projects in haemochromatosis, pre-eclampsia, aetiology of clubfoot and description of riboflavin responsive multiple acyl co-A dehydrogenase, including the well cited implication of ETFDH as a major causative gene.
Since 2004, she has used the roles of service clinical director of NHS laboratory and clinical genetics in the north of Scotland, and honorary consultant clinical geneticist to deliver high quality impactful research in gene discovery, characterisation, clinical epidemiology and rigorous technology assessment. Her work is highly collaborative both locally, nationally and internationally.
She is an author on 176 peer-reviewed publications, h-index is 43, with 8496 citations despite much of her work being in individually rare diseases. She has been holder / co-holder of more than 105 research grants totally >£17,358,540, of which £2,394,356 are current.
Highlights of her work have been discovery of new mechanism for autism- deregulation of EIF4E, documentation of UK patterns of prenatal diagnosis and pre-implantation genetic diagnosis over 27 years, evaluation of clinical approaches to risk stratification in familial cancer, genetic basis of primary familial basal cell calcification, Bazex-Dupre-Christol syndrome, discovery of EGFR copy number as a biomarker for response to gefitinib in oesophageal cancer (guideline recommendation). Furthermore, Zosia is one of few UK clinical geneticists to act as a principal investigator in interventional trials in genetic disease including Huntington’s disease (HD) and prevention in hereditary cancer.
Beyond research, as chair of the Scottish clinical genetics forum and genetics laboratory consortium she led NHS Scotland from testing for small panels of genes to exomes and genomes, with widespread cancer testing and beginnings of pharmacogenomics in everyday clinical practice, with testing rate 25% ahead of other UK nations prior to dissolution of UK genetic testing network.
In 2007 she won the SPARKS research award for her work on clubfoot, and professional recognition of her research and clinical practice was recognised through election to Fellowship of Royal College of Physicians of Edinburgh as a non-membership candidate in 2007, with FRCOG in 2009.
The three key impacts she is most proud of are:
- Services for Young People at risk of Huntington’s disease
Zosia’s team first described the devasting impact of growing up in a family with HD upon children and young people and demonstrated the need for specialised, age-appropriate education and support services. The work informed the development of new support services and educational materials for children and young people in Scotland and around the world, influencing the practice and training of healthcare professionals worldwide.
- Chief Investigator NHS Scotland in 100,000 Genomes-
Within the umbrella of Scottish genomes partnership, Zosia led 4 universities, 4 health boards, 4 clinics, 4 NHS labs, University sequencing provider and IT infrastructure to work with Genomics England and NHS Scotland National Services Division to deliver a real-world rigorous evaluation of whole genome sequencing, giving results to >1500 patients, informing Scottish genomic policy.
- Orkney BRCA1 gene variant-
Zosia recognised and documented a founder BRCA1 variant in her Orkney clinic. She worked with Jim Wilson and the ORCADES cohort to describe the population-based frequency of the first founder BRCA variant documented in a UK population, which arose in the remote isle of Westray in 1600s. She is now leading a pilot of population-based screening for the variant starting 3/7/23.
The publication of these findings in European Journal of Human Genetics drew worldwide media attention with >1.5 million BBC website hits overnight, two days of headline national news coverage, and was spread by 16 TV channels and 122 news outlets. Altmetric records the impact as already being the second most impactful paper ever in the journal. Testing for the variant has been proposed or those with Westray grandparents as standard of care in NHS Scotland and NHS England.
This work led to Woman and Home Magazine recognising her “Britain’s most amazing woman- Science Pioneer” for 2023.
- Publications
-
Page 2 of 2 Results 101 to 165 of 165
Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY
Journal of Neurology, Neurosurgery & Psychiatry, vol. 82, no. 12, pp. 1409-1412Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1136/jnnp.2010.209668
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2
Breast Cancer Research, vol. 13, no. 6, R110Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1186/bcr3052
Elucigene and LIPOchip for FH: NICE Diagnostic Assessment Review (DAR)
Contributions to Conferences: Other ContributionsHaplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers
Human Genetics, vol. 130, no. 5, pp. 685-699Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1007/s00439-011-1003-z
Parenting a child with clubfoot: a qualitative study
International Journal of Orthopaedic and Trauma Nursing, vol. 15, no. 4, pp. 176-184Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.ijotn.2011.02.004
- [ONLINE] View publication in Scopus
The first ninety families diagnosed with mutation positive familial hypercholesterolaemia in two lipid clinics in a Scottish Health Board area
25th Annual Conference on Heart, pp. e3Contributions to Journals: Abstracts- [ONLINE] DOI: https://doi.org/10.1016/j.atherosclerosis.2011.07.064
Germline mutations in RAD51D confer susceptibility to ovarian cancer
Nature Genetics, vol. 43, no. 9, pp. 879-882Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1038/ng.893
Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers
Human Molecular Genetics, vol. 20, no. 16, pp. 3304-3321Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1093/hmg/ddr226
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers: results from the consortium of investigators of modifiers of BRCA1/BRCA2
British Journal of Cancer, vol. 104, no. 8, pp. 1356-1361Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1038/bjc.2011.91
Is there evidence for aetiologically distinct subgroups of idiopathic congenital talipes equinovarus?: A case-only study and pedigree analysis
PloS ONE, vol. 6, no. 4, e17895Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1371/journal.pone.0017895
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/3562/1/Is_there_evidence.pdf
Tissue specific characterisation of Lim-kinase 1 expression during mouse embryogenesis
Gene Expression Patterns, vol. 11, no. 3-4, pp. 221-232Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.gep.2010.12.003
Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers
Journal of the National Cancer Institute, vol. 103, no. 2, pp. 105-116Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1093/jnci/djq494
Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study
The Lancet Oncology, vol. 11, no. 12, pp. 1127-1134Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/S1470-2045(10)70263-1
Association of the Variants CASP8 D302H and CASP10 V410I with Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Cancer Epidemiology, Biomarkers and Prevention, vol. 19, no. 11, pp. 2859-2868Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1158/1055-9965.EPI-10-0517
Mutation and association analysis of GEN1 in breast cancer susceptibility
Breast Cancer Research and Treatment, vol. 124, no. 1, pp. 283-288Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1007/s10549-010-0949-1
Pooled analysis indicates that the GSTT1 deletion, GSTM1 deletion, and GSTP1 Ile105Val polymorphisms do not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers
Breast Cancer Research and Treatment, vol. 122, no. 1, pp. 281-285Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1007/s10549-009-0601-0
Micro-magnetic resonance imaging and embryological analysis of wild-type and pma mutant mice with clubfoot
Journal of Anatomy, vol. 216, no. 1, pp. 108-120Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1111/j.1469-7580.2009.01163.x
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
Human Molecular Genetics, vol. 18, no. 22, pp. 4442-4456Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1093/hmg/ddp372
Deregulation of EIF4E: a novel mechanism for autism
Journal of Medical Genetics, vol. 46, no. 11, pp. 759-765Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1136/jmg.2009.066852
The developmental basis of clubfoot
16th Annual Conference of the International-Society-of-Development-Biologists, pp. S126Contributions to Journals: Abstracts- [ONLINE] DOI: https://doi.org/10.1016/j.mod.2009.06.245
Amniocentesis in the second trimester and congenital talipes equinovarus in the offspring: a population-based record linkage study in Scotland
Prenatal Diagnosis, vol. 29, no. 6, pp. 613-619Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1002/pd.2233
How young people find out about their family history of Huntington's disease
Social Science & Medicine, vol. 68, no. 10, pp. 1892-1900Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.socscimed.2009.02.049
Facial features in children with idiopathic congenital talipes equinovarus
Acta Orthopaedica Belgica, vol. 75, no. 1, pp. 57-63Contributions to Journals: ArticlesTreatment and Diagnosis of Behavioural Disorders
Patents: PatentsPredicting breast cancer risk: implications of a "weak" family history
Familial Cancer, vol. 7, no. 4, pp. 361-366Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1007/s10689-008-9197-5
Probability estimation models for prediction of BRCA1 and BRCA2 mutation carriers: COS compares favourably with other models
Familial Cancer, vol. 7, no. 3, pp. 199-212Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1007/s10689-007-9176-2
Protocol for stage 2 of the GaP study (genetic testing acceptability for Paget's disease of bone): a questionnaire study to investigate whether relatives of people with Paget's disease would accept genetic testing and preventive treatment if they were available
BMC Health Services Research, vol. 8, no. 116, pp. 116Contributions to Journals: Articles- [ONLINE] http://aura.abdn.ac.uk/handle/2164/247
- [ONLINE] DOI: https://doi.org/10.1186/1472-6963-8-116
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/2653/1/Langston_2008.pdf
New mutations, genotype phenotype studies and manifesting carriers in giant axonal neuropathy
Journal of Neurology, Neurosurgery & Psychiatry, vol. 78, no. 11, pp. 1267-1270Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1136/jnnp.2007.118968
The essential role of genetic counseling in inherited thrombophilia
Seminars in Hematology, vol. 44, no. 2, pp. 126-129Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1053/j.seminhematol.2007.01.003
Young people's experiences of growing up in a family affected by Huntington's disease
Clinical Genetics, vol. 71, no. 2, pp. 120-129Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1111/j.1399-0004.2006.00702.x
The C677T polymorphism in the methylenetetrahydrofolate reductase gene (MTHFR), maternal use of folic acid supplements, and risk of isolated clubfoot: a case-parent triad analysis
American Journal of Epidemiology, vol. 164, no. 9, pp. 852-861Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1093/AJE/KWJ285
Genetic nurse counsellors can be an acceptable and cost-effective alternative to clinical geneticists for breast cancer risk genetic counselling: Evidence from two parallel randomised controlled equivalence trials
British Journal of Cancer, vol. 95, pp. 435-444Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1038/sj.bjc.6603248
Gross rearrangements of the MECP2 gene are found in both classical and atypical Rett syndrome patients
Journal of Medical Genetics, vol. 43, no. 5, pp. 451-456Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1136/jmg.2005.033464
Cluster randomized trial of a multifaceted primary care decision-support intervention for inherited breast cancer risk
Family Practice, vol. 23, no. 5, pp. 537-44Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1093/fampra/cml026
Opening doors for young people in Huntington's Disease families
World Congress on Huntingtons Disease 2005, pp. A52Contributions to Journals: AbstractsImpact of a cancer registry-based genealogy service to support clinical genetics services
Familial Cancer, vol. 3, no. 2, pp. 139-141Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1023/B:FAME.0000039865.29247.75
- [ONLINE] View publication in Scopus
Exploring the effects of the MTHFR C677T polymorphism on the risk of clubfoot: an analysis of case-parent triads in the UK
Journal of Epidemiology and Community Health, vol. 58, pp. A1-A2Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1136/jech.58.1.1
Factor analysis can be a useful standard setting tool in a high stakes OSCE assessment
Medical Education, vol. 38, pp. 825-831Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1111/j.1365-2929.2004.01821.x
Genetics and epidemiology of idiopathic congenital talipes equinovarus
Journal of Pediatric Orthopedics, vol. 23, no. 2, pp. 265-272Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1097/00004694-200303000-00025
Congenital talipes equinovarus (clubfoot): a disorder of the foot but not the hand
Journal of Anatomy, vol. 202, no. 1, pp. 37-42Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1046/j.1469-7580.2003.00147.x
Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review
Thrombosis and Haemostasis, vol. 87, no. 5, pp. 779-785Contributions to Journals: ArticlesTeaching undergraduates about familial breast cancer: comparison of a computer assisted learning (CAL) package with a traditional tutorial approach
EJHG : European journal of human genetics : the official journal of the European Society of Human Genetics. , vol. 9, pp. 953-956Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1038/sj.ejhg.5200751
Stored tissue may be important for the future care of families
British Medical Journal, vol. 322, no. 7293, pp. 1060-1060Contributions to Journals: Letters- [ONLINE] DOI: https://doi.org/10.1136/bmj.322.7293.1060
Folate and breast cancer: the role of polymorphsisms in methylenetetrahydrofolate reductase (MTHFR)
EJHG : European journal of human genetics : the official journal of the European Society of Human Genetics. , vol. 9, pp. 275Contributions to Journals: AbstractsVitamin D and breast cancer: interaction between dietary vitamin D and genetic variation in the vitamin D receptor may be implicated in the aetiology of breast cancer
EJHG : European journal of human genetics : the official journal of the European Society of Human Genetics. , vol. 9, no. Supplement 1, pp. 1411Contributions to Journals: ArticlesEpidemiology and genetic theories in the etiology of congenital talipes equinovarus
Bulletin: Hospital for Joint Diseases, vol. 58, no. 1, pp. 59-64Contributions to Journals: Articles- [ONLINE] View publication in Scopus
Incorrect recall of residual risk three years after carrier screening for cystic fibrosis: A comparison of two-step and couple screening
American Journal of Obstetrics and Gynecology, vol. 181, no. 1, pp. 165-169Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/S0002-9378(99)70454-0
Fragile X syndrome with FMR1 and FMR2 deletion
Journal of Medical Genetics, vol. 36, pp. 565-566Contributions to Journals: ArticlesHaemochromatosis mutations in North-East Scotland
British Journal of Haematology, vol. 106, pp. 385-387Contributions to Journals: ArticlesNon-penetrance in a MODY 3 family with a mutation in the hepatic nuclear factor 1 alpha gene: implications for predictive testing
EJHG : European journal of human genetics : the official journal of the European Society of Human Genetics. , vol. 7, pp. 729-732Contributions to Journals: ArticlesCystic fibrosis screening policies [9]
Lancet, vol. 347, no. 9006, pp. 969Contributions to Journals: Letters- [ONLINE] DOI: https://doi.org/10.1016/S0140-6736(96)91455-5
- [ONLINE] View publication in Scopus
Willingness to pay for antenatal carrier screening for cystic fibrosis
Health Economics, vol. 4, no. 6, pp. 439-452Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1002/hec.4730040602
- [ONLINE] View publication in Scopus
Antenatal screening for carriers of cystic fibrosis: Randomised Trial of stepwise v couple screening
BMJ, vol. 310, no. 6976Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1136/bmj.310.6976.353
- [ONLINE] View publication in Scopus
Antenatal carrier screening for cystic fibrosis
Biomedicine and Pharmacotherapy, vol. 49, no. 10, pp. 472-473Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/0753-3322(96)82694-1
- [ONLINE] View publication in Scopus
Cystic fibrosis mutation analysis: Report from 22 U.K. regional genetics laboratories
Human Mutation, vol. 6, no. 4, pp. 326-333Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1002/humu.1380060406
- [ONLINE] View publication in Scopus
Stepwise or couple antenatal carrier screening for cystic fibrosis?: Women's preferences and willingness to pay
Journal of Medical Genetics, vol. 32, no. 4, pp. 282-283Contributions to Journals: Articles- [ONLINE] https://jmg.bmj.com/content/32/4/282
- [ONLINE] View publication in Scopus
Identical intragenic microsatellite haplotype found in cystic fibrosis chromosomes bearing mutation G551D in Irish, English, Scottish, Breton and Czech Patients
Human Heredity, vol. 45, no. 1, pp. 6-12Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1159/000154249
- [ONLINE] View publication in Scopus
Evaluation of laboratory methods for cystic fibrosis carrier screening: Reliability, sensitivity, specificity, and costs
Journal of Medical Genetics, vol. 31, no. 7, pp. 545-550Contributions to Journals: Articles- [ONLINE] View publication in Scopus
Counting the benefits of screening: A pilot study of willingness to pay for cystic fibrosis carrier screening
Journal of Medical Screening, vol. 1, no. 2, pp. 82-83Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1177/096914139400100203
- [ONLINE] View publication in Scopus
Screening for cystic fibrosis: medical and ethical issues
Current Obstetrics and Gynaecology, vol. 3, no. 1, pp. 61-62Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/0957-5847(93)90065-W
- [ONLINE] View publication in Scopus
Antenatal cystic fibrosis carrier screening—whether, when and how?
Paediatric and Perinatal Epidemiology, vol. 7, no. 4, pp. 368-375Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1111/j.1365-3016.1993.tb00416.x
- [ONLINE] View publication in Scopus
Preimplantation diagnosis: Preimplantation diagnosis or chorionic villus biopsy? women's attitudes and preferences
Human Reproduction, vol. 8, no. 12, pp. 2192-2196Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1093/oxfordjournals.humrep.a138002
- [ONLINE] View publication in Scopus
Prevalence of cystic fibrosis mutations in the Grampian region of Scotland
Journal of Medical Genetics, vol. 30, no. 4, pp. 316-317Contributions to Journals: Articles- [ONLINE] View publication in Scopus
Prenatal diagnosis for the cystic fibrosis mutation 1717‐1, G→A using arms
Prenatal Diagnosis, vol. 12, no. 10, pp. 845-849Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1002/pd.1970121012
- [ONLINE] View publication in Scopus
Screening for carriers of cystic fibrosis
British Medical Journal, vol. 302, no. 6767, pp. 53Contributions to Journals: Letters- [ONLINE] DOI: https://doi.org/10.1136/bmj.302.6767.53
- [ONLINE] View publication in Scopus